Trials / Recruiting
RecruitingNCT07191223
Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in France
Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners and Specialists in Endemic Areas and Outside Endemic Areas in France
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Tick-borne encephalitis is a relatively rare disease (approximately 35 cases diagnosed per year), but most cases (86%) are due to contamination in France via a tick bite. Of the 71 cases reported over two years (May 2021 to May 2023), 94% of patients were hospitalized. It is therefore important to consider and diagnose at the first signs to ensure appropriate follow-up and also to implement primary prevention in endemic/at-risk areas.
Conditions
Timeline
- Start date
- 2024-02-16
- Primary completion
- 2026-02-16
- Completion
- 2026-02-16
- First posted
- 2025-09-24
- Last updated
- 2025-09-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07191223. Inclusion in this directory is not an endorsement.